Re-infected with coronavirus patients are not contagious – found in South Korea

About 300 recovered from coronavirus of patients again tested for the virus and who was again a positive result themselves more than anyone else, according to representatives of the health sector of South Korea.

Preliminary results, presented on Monday by the Korean centers for control and prevention of diseases, lead to the conclusion that the people who have been infected with COVID-19, develop immunity to the disease.

Representatives of the health sector were observed in 285 patients who recovered from the disease, but then got sick again. They found that none of the 790 people who came in contact with these 285 patients, was infected with coronavirus.

As a result, South Korea canceled a 14-day quarantine imposed for discharged patients, according to The Wall Street Journal.

The country has also replaced the term “reinfection” on the “re-discovery” in the description of those who have a second time found the coronavirus after recovery.

“Until we saw people who came in contact with the patients re-infected with coronavirus, is sick themselves,”– said on Monday, Yoon Tae-Ho from the Ministry of health of South Korea, according to The Wall Street Journal.

In South Korea found more than 11 thousand confirmed cases of coronavirus. More than 470 of recovered patients for the second time contracted the coronavirus after discharge, and representatives of the health system interested in the question whether it is possible that patients not infected again, and there was a reactivation of the virus. They believe that the tests can just fix the dead fragments of the virus. “We pay more attention to the theory that the dead fragments of the virus remain in the body of a recovered patient, since we have not seen evidence of infectiousness”,- told the news publication Ki Moran, Professor of National cancer center.

Some patients who experienced a coronavirus, again showed a positive result up to 82 days after the first infection, according to Bloomberg.


Show More

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button

Please disable your ad blocker

We know you are here for the stories. Not the ads. But we need the ads to keep the lights on. So please whitelist